PubMed Health⌕ Search

Biomedical subjects

S Madhavan

Publications and source records attributed to S Madhavan.

At least 91 records · Page 5Linked to original sources
PubMed1983

Effect of 2-(3,4-Dichlorophenoxy)-triethylamine on the Synthensis of cis-Polyisoprene in Guayule Plants (Parthenium argentatum Gray).

The application of 2-(3,4-dichlorophenoxy)-triethylamine to guayule (Parthenium argentatum Gray var 593) plants results in a 2-fold stimulation of rubber synthesis and a 1.5- to 3-fold increase in mevalonic acid kinase, isopentenyl pyrophosphate isomerase, and rubber transferase. The increase in these enzymic activities accounts in part for the chemical induction of rubber synthesis.

Journal Article↗
PubMed1982

Localization of ribulose bisphosphate carboxylase in the guard cells by an indirect, immunofluorescence technique.

Ribulose bisphosphate carboxylase, a key enzyme in the photosynthetic carboxylation process, has been localized through an indirect immunofluorescent technique in the guard cells of some of the 41 species of plants examined. This sample includes 17 families of both dicotyledons and monocotyledons, one gymnosperm, and one pteridophyte. Plants were selected to represent all of the three major photosynthetic categories, namely C(3), C(4), and Crassulacean acid metabolism. Antibodies raised against tobacco (Nicotiana tabacum L.) ribulose bisphosphate carboxylase were used for this immunofluorescent study. A good degree of fluorescence was observed in the guard cells of seven out of 21 species exhibiting Crassulacean acid metabolism. C(3) plants exhibited a very low degree (almost negligible) of fluorescence, while the C(4) species did not exhibit any fluorescence.

Journal Article↗
PubMed1981

The potential effect of blood pressure reduction on cardiovascular disease. A cautionary note.

The risk of cardiovascular disease (CVD) at various levels of systolic blood pressure (BP) and the potential benefit of BP reduction have been estimated by constructing probability tables for extended periods based on the Framingham Study data. These estimates demonstrate that systolic BP alone delineates subgroups of persons with widely divergent risk of CVD, depending both on their demographic and clinical characteristic. For example, the disparity in prognosis is such that some persons with a systolic BP of 160 mm Hg are at greater risk of subsequent CVD than others with a systolic BP of 195 mm Hg. The potential benefit to be derived from systolic BP reduction shows similarly wide variation, so initial pressure alone does not precisely predict the gain that might accompany BP reduction. Measures of greater prognostic value are needed to enhance the value of BP determination.

Adult↗